Richard Jones
Directeur Général chez AdrenoMed AG
Profil
Richard Jones currently works at AdrenoMed AG, as Chief Executive Officer from 2022.
Dr. Jones also formerly worked at Fusion Antibodies Plc, as Chief Executive Officer & Director from 2021 to 2022, Akinion Pharmaceuticals AB, as Chief Executive Officer, BrYet Ltd., as Chief Executive Officer & Director in 2020, Holostem Terapie Avanzate S R L, as Chief Executive Officer, Genzyme Corp., as Director-Oncology & Transplant Portfolio, GSK Plc, as Vice President-Global Commercial Leader, Novartis UK Ltd., as VP-Medicines Commercialization, and Akcea Therapeutics UK Ltd., as Senior Vice President & Head-Europe.
Dr. Jones received his undergraduate degree and doctorate degree from the University of Surrey.
Postes actifs de Richard Jones
| Sociétés | Poste | Début |
|---|---|---|
AdrenoMed AG
 AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Directeur Général | 15/03/2022 |
Anciens postes connus de Richard Jones
| Sociétés | Poste | Fin |
|---|---|---|
| FUSION ANTIBODIES PLC | Directeur Général | 11/03/2022 |
| BrYet Ltd. | Directeur Général | 01/07/2020 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| GSK PLC | Corporate Officer/Principal | - |
Novartis UK Ltd.
 Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom. | Corporate Officer/Principal | - |
Formation de Richard Jones
| University of Surrey | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GSK PLC | Health Technology |
| FUSION ANTIBODIES PLC | Health Services |
| Entreprise privées | 7 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Novartis UK Ltd.
Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom. | Health Technology |
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Health Technology |
| Akcea Therapeutics UK Ltd. | |
| BrYet Ltd. | |
| Holostem Terapie Avanzate S R L | |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Health Technology |
